ANLN and hepatocellular carcinoma: In summary, we found that HSG (PTTG1, ANLN, KIF2C, TPX2) was significantly upregulated in hepatocellular carcinoma and that the constructed prognostic risk model can reliably predict the prognosis of hepatocellular carcinoma patients.